[{"address1": "455 East Medical Center Boulevard", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77598", "country": "United States", "phone": "281 671 5150", "website": "https://www.fibrobiologics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. The company was incorporated in 2021 and is based in Houston, Texas.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  O'Heeron", "age": 59, "title": "Founder, Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 950723, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hamid  Khoja Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 423119, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.95, "open": 10.25, "dayLow": 9.4063, "dayHigh": 10.3, "regularMarketPreviousClose": 9.95, "regularMarketOpen": 10.25, "regularMarketDayLow": 9.4063, "regularMarketDayHigh": 10.3, "volume": 31460, "regularMarketVolume": 31460, "averageVolume": 140662, "averageVolume10days": 72990, "averageDailyVolume10Day": 72990, "bidSize": 900, "askSize": 800, "marketCap": 322427872, "fiftyTwoWeekLow": 6.53, "fiftyTwoWeekHigh": 46.0, "fiftyDayAverage": 11.918333, "twoHundredDayAverage": 11.918333, "currency": "USD", "enterpriseValue": 313746624, "floatShares": 24692347, "sharesOutstanding": 32634400, "dateShortInterest": 1707955200, "heldPercentInsiders": 0.30412, "shortRatio": 0.36, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -19058000, "enterpriseToEbitda": -35.484, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "FBLG", "underlyingSymbol": "FBLG", "shortName": "FibroBiologics, Inc.", "longName": "FibroBiologics, Inc.", "firstTradeDateEpochUtc": 1706797800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "6752a379-a671-33c4-8602-9f32d42c8f6a", "gmtOffSetMilliseconds": -18000000, "currentPrice": 9.88, "recommendationKey": "none", "totalCash": 9163000, "totalCashPerShare": 0.282, "ebitda": -8842000, "totalDebt": 1888000, "quickRatio": 0.998, "currentRatio": 1.003, "debtToEquity": 150.678, "returnOnAssets": -0.66753995, "freeCashflow": 3831500, "operatingCashflow": -6401000, "financialCurrency": "USD", "trailingPegRatio": null}]